Progress in Neurotherapeutics and Neuropsychopharmacology

Table of Contents - 2007 - Volume 2, Issue 01  

As this article doesn't contain an abstract, the image below is necessary to enable the article to be indexed by certain search engines. The resolution of the full-text PDF is much higher than that shown here.

Review Article

Chemoradiotherapy for primary CNS lymphoma 1

Antonio M.P. Omuro a1c1, Joachim Yahalom a2 and Lauren E. Abrey a3
a1 Division de Neurologie Mazarin – Groupe Hospitalier Pitie-Salpetriere, Paris, France; Email: antonio.omuro@psl.ap-hop-paris.fr
a2 Department of Radiotherapy – Memorial Sloan-Kettering Cancer Center, New York, NY, USA;Email: yahalomj@mskcc.org
a3 Department of Neurology – Memorial Sloan-Kettering Cancer Center, New York, NY, USA;Email: abreyl@mskcc.org

Article author query
omuro am   [PubMed][Google Scholar] 
yahalom j   [PubMed][Google Scholar] 
abrey le   [PubMed][Google Scholar] 

Key Words: primary central nervous system lymphone; Non-hodgkin's lymphs; brain neoplasm; chemotherapy; radiotherapy.

Correspondence:
c1 Correspondence should be addressed to: Antonio M.P. Omuro, MD, Groupe Hospitalier Pitie-Salpetriere, Federation de Neurologie Mazarin, 47, Bd de l'Hopital, 75661 Paris Cedex 13-France; Ph: +33 1 42 16 41 60; Fax: +33 1 42 16 03 75; Email: antonio.omuro@psl.ap-hop-paris.fr.

Footnotes

1 Original article: Chemoradiotherapy for primary CNS lymphoma: An intent-to-treat analysis with complete follow-up. Published in NEUROLOGY 64 (1): 69–74, January 2005.All authors have read and approved this chapter. Informed consent was obtained from all subjects and/or guardians involved in this study. The authors are responsible for the accuracy of the references.